cancer-immunotherapy

Documents about cancer-immunotherapy

• Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer#121336ClinicalTrials.gov
• Neoadjuvant Immunotherapy With Durvalumab and Tremelimumab for Bladder Cancer Patients Ineligible for Cisplatin#180379ClinicalTrials.gov
• Omission of Surgery for Triple-negative Breast Cancer in Complete Response After Neoadjuvant Chemo-immunotherapy#181759ClinicalTrials.gov
• LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNG#195333ClinicalTrials.gov
• Trial watch: antibody-drug conjugates in cancer therapy#205878HAL (France)
• Chemo-immunotherapy (Gemcitabine, Interferon-alpha 2b and p53 SLP) in Patients With Platinum-resistant Ovarian Cancer#256873ClinicalTrials.gov
• Neoadjuvant Immunotherapy Combined With the Anti-GDF-15 Antibody Visugromab to Treat Muscle Invasive Bladder Cancer#256891ClinicalTrials.gov
• Study to Identify Biomarkers of Oral Cavity Cancer Response to Neoadjuvant Immunotherapy Prior to Definitive Surgery#268021ClinicalTrials.gov
• Immunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 Levels#272345ClinicalTrials.gov
• A Study to Assess the Ability of Stereotactic Radiotherapy to Restore the Efficacy of Immunotherapy in Patients With Metastatic Cancer.#283055ClinicalTrials.gov
• Trilaciclib Combined With Concurrent Chemoradiotherapy and Immunotherapy in the Treatment of Esophageal Cancer#383550ClinicalTrials.gov
• Iparomlimab Tolvorlimab as Neoadjuvant Immunotherapy for Locally Advanced Gastric Adenocarcinoma With Microsatellite Instability/Mismatch Repair Deficiency#414497ClinicalTrials.gov
• Clinical Study on the Expression of PHGDH and Its Prognostic Value in Colorectal Cancer Patients Receiving Immunotherapy#442077ClinicalTrials.gov
• Customized Circulating Tumor DNA Testing for Cervical Cancer Recurrence Surveillance and Treatment Decisions#451478ClinicalTrials.gov
• E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer#458382ClinicalTrials.gov
• Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer#481750ClinicalTrials.gov
• Neoadjuvant Long-course Chemoradiotherapy Followed by Immunotherapy for Locally Advanced Mid-low Rectal Cancer#668816ClinicalTrials.gov
• Relation Between Tumor-draining Lymph Nodes Metastasis Pattern and Non-small Cell Lung Cancer Neoadjuvant Immunotherapy Effectiveness#674899ClinicalTrials.gov
• Second-line Immunotherapy for ES-SCLC#852143ClinicalTrials.gov
• Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC)#238101ClinicalTrials.gov
• Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)#127580ClinicalTrials.gov
• QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy#256869ClinicalTrials.gov
• Ipilimumab and GMCSF Immunotherapy for Prostate Cancer#835667ClinicalTrials.gov
• PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer#859646ClinicalTrials.gov
• Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study#181777ClinicalTrials.gov
• The long-term effectiveness of specific immunotherapy in cat allergy: a real-life study#361737Figshare
• Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung Cancer#340174IRIS
• Modulation of the response to immunotherapy in triple-negative breast cancer: the role of the microbiota and microbial metabolites in the tumor microenvironment#642682Europe PMC
• Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer#143583ClinicalTrials.gov
• Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer#474777ClinicalTrials.gov
• Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer#810240ClinicalTrials.gov
• Chemoradiotherapy Plus Immunotherapy Followed by Surgery for Esophageal Cancer#121339ClinicalTrials.gov
• PD-1 Inhibitors Consolidation in Extensive-stage Small Cell Lung Cancer#127586ClinicalTrials.gov
• Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI)#152429ClinicalTrials.gov
• RhGM-CSF as Adjuvant Immunotherapy in Treating Stage III Colon Cancer#234435ClinicalTrials.gov
• Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Transitional Cell Carcinoma#307465ClinicalTrials.gov
• Immunodominance Hierarchy of Endogenous BBN963 Bladder Cancer Antigens Remains Stable Under Anti-PD1 and Anti-CTLA4 Immunotherapy#310922bioRxiv / medRxiv
• Anlotinib Plus Toripalimab as First-line Treatment for Advanced Gastric Cancer With ECOG 2 (APICAL-GC)#332742ClinicalTrials.gov
• Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]#369821ClinicalTrials.gov
• Study of Safety and Efficacy of Novel Immunotherapy Combinations in Patients With Triple Negative Breast Cancer (TNBC).#373604ClinicalTrials.gov
• Impact of Body Mass Index and Lipid Metabolism on Anti-PD-1 Immunotherapy Outcomes in Colorectal Cancer#390906ClinicalTrials.gov
• Omega-3 Supplementation and Immunotherapy in Gastric Cancer: A Phase II Trial#435752ClinicalTrials.gov
• Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck#451459ClinicalTrials.gov
• QL1706 Combined With Cisplatin/Paclitaxel as Neoadjuvant Therapy for Cervical Cancer#623522ClinicalTrials.gov
• Safety and Efficacy of Leucine-Restricted Diet Combined With Chemotherapy and Immunotherapy in Advanced Gastric Cancer#640557ClinicalTrials.gov
• The Effect of Diet and Exercise on ImmuNotherapy and the Microbiome (EDEN)#18610ClinicalTrials.gov
• Feasibility Study of Intra-Tumoral Lipopolysaccharide Immunotherapy for Intra-Abdominal#148761ClinicalTrials.gov
• Combination of Rituximab and NK Immunotherapy for B Lymphoma#238107ClinicalTrials.gov
• Cellular immunotherapy in melanoma: the next frontier in cancer treatment.#297313NCBI PubMed Central
• The Intestinal Microbiome in Triple Negative Breast Cancer Treated with Immunotherapy#303723ClinicalTrials.gov